Förster M - Search Results

1

The Molecular Basis for Remyelination Failure in Multiple Sclerosis.

Gruchot J, Weyers V, Göttle P, Förster M, Hartung HP, Küry P, Kremer D. Gruchot J, et al. Among authors: forster m. Cells. 2019 Aug 3;8(8):825. doi: 10.3390/cells8080825. Cells. 2019. PMID: 31382620 Free PMC article. Review.

2

Human endogenous retrovirus type W envelope protein inhibits oligodendroglial precursor cell differentiation.

Kremer D, Schichel T, Förster M, Tzekova N, Bernard C, van der Valk P, van Horssen J, Hartung HP, Perron H, Küry P. Kremer D, et al. Among authors: forster m. Ann Neurol. 2013 Nov;74(5):721-32. doi: 10.1002/ana.23970. Epub 2013 Sep 16. Ann Neurol. 2013. PMID: 23836485

3

The neutralizing antibody GNbAC1 abrogates HERV-W envelope protein-mediated oligodendroglial maturation blockade.

Kremer D, Förster M, Schichel T, Göttle P, Hartung HP, Perron H, Küry P. Kremer D, et al. Among authors: forster m. Mult Scler. 2015 Aug;21(9):1200-3. doi: 10.1177/1352458514560926. Epub 2014 Dec 5. Mult Scler. 2015. PMID: 25480862

4

Rescuing the negative impact of human endogenous retrovirus envelope protein on oligodendroglial differentiation and myelination.

Göttle P, Förster M, Gruchot J, Kremer D, Hartung HP, Perron H, Küry P. Göttle P, et al. Among authors: forster m. Glia. 2019 Jan;67(1):160-170. doi: 10.1002/glia.23535. Epub 2018 Nov 14. Glia. 2019. PMID: 30430656

5

Managing Risks with Immune Therapies in Multiple Sclerosis.

Förster M, Küry P, Aktas O, Warnke C, Havla J, Hohlfeld R, Mares J, Hartung HP, Kremer D. Förster M, et al. Drug Saf. 2019 May;42(5):633-647. doi: 10.1007/s40264-018-0782-8. Drug Saf. 2019. PMID: 30607830 Review.

6

Drug Treatment of Clinically Isolated Syndrome.

Förster M, Graf J, Mares J, Aktas O, Hartung HP, Kremer D. Förster M, et al. CNS Drugs. 2019 Jul;33(7):659-676. doi: 10.1007/s40263-019-00647-x. CNS Drugs. 2019. PMID: 31290079 Review.

7

Case Report: A Case of Severe Clinical Deterioration in a Patient With Multiple Sclerosis.

Breitkopf K, Aytulun A, Förster M, Kraus B, Turowski B, Huppert D, Goebels N, Hefter H, Aktas O, Metz I, Brück W, Reifenberger G, Hartung HP, Albrecht P. Breitkopf K, et al. Among authors: forster m. Front Neurol. 2020 Aug 18;11:782. doi: 10.3389/fneur.2020.00782. eCollection 2020. Front Neurol. 2020. PMID: 32973648 Free PMC article.

8

Neurological manifestations of severe acute respiratory syndrome coronavirus 2-a controversy 'gone viral'.

Förster M, Weyers V, Küry P, Barnett M, Hartung HP, Kremer D. Förster M, et al. Brain Commun. 2020 Sep 17;2(2):fcaa149. doi: 10.1093/braincomms/fcaa149. eCollection 2020. Brain Commun. 2020. PMID: 33210085 Free PMC article. Review.

9

An unmet clinical need: roads to remyelination in MS.

Göttle P, Förster M, Weyers V, Küry P, Rejdak K, Hartung HP, Kremer D. Göttle P, et al. Among authors: forster m. Neurol Res Pract. 2019 Jul 8;1:21. doi: 10.1186/s42466-019-0026-0. eCollection 2019. Neurol Res Pract. 2019. PMID: 33324887 Free PMC article. Review.

10

Case Report: Successful Stabilization of Marburg Variant Multiple Sclerosis With Ocrelizumab Following High-Dose Cyclophosphamide Rescue.

Koska V, Förster M, Brouzou K, Hatami M, Arat E, Aytulun A, Albrecht P, Aktas O, Küry P, Meuth SG, Kremer D. Koska V, et al. Among authors: forster m. Front Neurol. 2021 Jun 23;12:696807. doi: 10.3389/fneur.2021.696807. eCollection 2021. Front Neurol. 2021. PMID: 34248832 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

992 results

Search Page